Overexpression of p53 explains isotretinoin's teratogenicity

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|27|1|91-93

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.27, Iss.1, 2018-01, pp. : 91-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Correlation of p53 Protein Overexpression and p53 Antibodies in Serum of Patients with Transitional Cell Carcinoma of the Urinary Bladder

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Allelic Loss at TP53 Is Not Related to p53 Protein Overexpression in Primary Human Endometrial Carcinomas

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 317-325

Karger

Access to resources Recommend Favorite

Amplification of c-myc in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overexpression

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Cooccurrence of Reduced Expression of α-Catenin and Overexpression of p53 Is a Predictor of Lymph Node Metastasis in Early Gastric Cancer

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 131-137

Karger

Access to resources Recommend Favorite

Prognostic Significance of p53 Nuclear Overexpression in Patients of Muscle Invasive Urinary Bladder Carcinoma Treated with Cystectomy

By  

Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. : 42-46

Karger

Access to resources Recommend Favorite